Exiris SRL

Exiris SRL is an SME in Roma, Italy that has taken part in 2 EU-funded projects since 2015, receiving €520k in EU funding.

EU funding received€520k
EU projects2
As coordinator0
Running now0
First EU project2015
Latest project2019
CountryItaly
EU registration (PIC)947594747
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Exiris SRL's own share of each project, not the project's full budget.

  • Horizon 2020€520k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • Magicbullet ReloadedPartner

    Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €262ktheir share
  • MAGICBULLETPartner

    Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €258ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cell biology
  • colorectal cancer
  • drug discovery
  • immunotherapy
  • medicinal chemistry
  • oncology
  • pharmaceutical drugs
  • physiology
  • toxicology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime